Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1992-12-11
pubmed:abstractText
This article discusses the relative contraindications to the use of vasoconstrictor in patients currently medicated with tricyclic antidepressants, monoamine oxidase inhibitors, phenothiazines and beta-blockers. It reviews drug interactions and emphasizes potential detrimental systemic effects that epinephrine contained in local anesthetics can have when administered concomitantly with these drugs. Finally, special considerations are expressed concerning patients who abuse illicit drugs such as cocaine.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
D
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0030-4220
pubmed:author
pubmed:issnType
Print
pubmed:volume
74
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
692-7
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:1359489-Acute Disease, pubmed-meshheading:1359489-Adrenergic beta-Antagonists, pubmed-meshheading:1359489-Anesthesia, Dental, pubmed-meshheading:1359489-Anesthesia, Local, pubmed-meshheading:1359489-Antidepressive Agents, Tricyclic, pubmed-meshheading:1359489-Antipsychotic Agents, pubmed-meshheading:1359489-Arrhythmias, Cardiac, pubmed-meshheading:1359489-Cocaine, pubmed-meshheading:1359489-Dental Care for Disabled, pubmed-meshheading:1359489-Drug Interactions, pubmed-meshheading:1359489-Epinephrine, pubmed-meshheading:1359489-Heart Conduction System, pubmed-meshheading:1359489-Hemodynamics, pubmed-meshheading:1359489-Humans, pubmed-meshheading:1359489-Hypertension, pubmed-meshheading:1359489-Monoamine Oxidase Inhibitors, pubmed-meshheading:1359489-Nordefrin, pubmed-meshheading:1359489-Norepinephrine, pubmed-meshheading:1359489-Phenothiazines, pubmed-meshheading:1359489-Substance-Related Disorders, pubmed-meshheading:1359489-Tachycardia, pubmed-meshheading:1359489-Vasoconstrictor Agents
pubmed:year
1992
pubmed:articleTitle
Contraindications to vasoconstrictors in dentistry: Part III. Pharmacologic interactions.
pubmed:affiliation
Section of Oral Medicine, School of Dental Medicine, Université Laval, Ste.-Foy, Quebec, Canada.
pubmed:publicationType
Journal Article, Review